Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection

José M. Gatell, J. M. Miró, E. Aznar, X. Camé, V. Moreno, X. Vidal, D. Podzamczer, F. Gudiol, A. Casanova, B. Clotet, A. Jou, J. M. Miró, J. M. Gatell, E. Aznar, J. M.Martinez Vázquez, I. Ocaña, I. Ruiz Camps, R. Cisterna, J. M. Santamaria, J. CosínJ. Gómez, J. J. Vázquez, A. Gil Aguado, M. E. Valencia, L. Buzón, J. M.González Lahoz, R. M. Polo, V. Moreno, D. Zulaica, F. Rodriguez Arrondo

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Fingerprint Dive into the research topics of 'Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection'. Together they form a unique fingerprint.

Medicine & Life Sciences